Cleared Traditional

K222065 - Passeo-35 Xeo Peripheral Dilatation Catheter (FDA 510(k) Clearance)

Feb 2023
Decision
218d
Days
Class 2
Risk

K222065 is an FDA 510(k) clearance for the Passeo-35 Xeo Peripheral Dilatation Catheter. This device is classified as a Catheter, Angioplasty, Peripheral, Transluminal (Class II - Special Controls, product code LIT).

Submitted by Biotronik, Inc. (Lake Oswego, US). The FDA issued a Cleared decision on February 16, 2023, 218 days after receiving the submission on July 13, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250.

Submission Details

510(k) Number K222065 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2022
Decision Date February 16, 2023
Days to Decision 218 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code LIT — Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250

Similar Devices — LIT Catheter, Angioplasty, Peripheral, Transluminal

All 8
Armada™ 14 NC PTA Catheter
K252512 · Abbott Medical · Feb 2026
Passeo-35 Xeo Peripheral Dilatation Catheter
K250706 · Biotronik, Inc. · Apr 2025
Oscar Peripheral Multifunctional Catheter system
K241711 · Biotronik, Inc. · Jul 2024
Sterling™ MONORAIL™ PTA Balloon Dilatation Catheter (H74939031404020 )
K241683 · Boston Scientific Corporation · Jul 2024
Highlander™ 014 PTA Balloon Dilatation Catheter
K223177 · C.R. Bard, Inc. · Jan 2023
Oscar Peripheral Multifunctional Catheter system
K214038 · Biotronik, Inc. · Jul 2022